San Diego Business Journal

The 350 attendees are proven men and women of action.

In a past opinion piece, that’s how Ida Deichaite described UC San Diego Moores Cancer Center’s Next Generation Precision Oncology symposium. She’s the director of Moores’ office of industry relations, and the lead event organizer.

The symposium, slated for Feb. 21 at Moores, unites cancer researchers across biotech, academia and clinical settings. The focus is on translating groundbreaking oncology discoveries into therapeutics. Hence the emphasis on action.

At the event, top researchers will share unpublished data, for the sake of brainstorming and sparking partnerships.

“We are proud to hear from past attendees about a high number of collaborations and alliances stemming from the event that address the needs for accelerated research,” Deichaite said in a news release.

Speakers include Gordon Mills, director of precision oncology at the Knight Cancer Institute. His talk will revolve around delivering on the promise of precision oncology.

The event, which has limited space, is open to biotech and academia.